Lhyfe SA (LHYFE) - Net Assets
Based on the latest financial reports, Lhyfe SA (LHYFE) has net assets worth €50.73 Million EUR (≈ $59.31 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€237.47 Million ≈ $277.63 Million USD) and total liabilities (€186.73 Million ≈ $218.31 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Lhyfe SA liquidity resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €50.73 Million |
| % of Total Assets | 21.36% |
| Annual Growth Rate | 77.38% |
| 5-Year Change | 2791.29% |
| 10-Year Change | N/A |
| Growth Volatility | 137.99 |
Lhyfe SA - Net Assets Trend (2019–2024)
This chart illustrates how Lhyfe SA's net assets have evolved over time, based on quarterly financial data. Also explore Lhyfe SA total assets for the complete picture of this company's asset base.
Annual Net Assets for Lhyfe SA (2019–2024)
The table below shows the annual net assets of Lhyfe SA from 2019 to 2024. For live valuation and market cap data, see Lhyfe SA (LHYFE) market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €71.67 Million ≈ $83.80 Million |
-30.02% |
| 2023-12-31 | €102.42 Million ≈ $119.74 Million |
-23.33% |
| 2022-12-31 | €133.58 Million ≈ $156.17 Million |
+2261.90% |
| 2021-12-31 | €-6.18 Million ≈ $-7.22 Million |
-349.25% |
| 2020-12-31 | €2.48 Million ≈ $2.90 Million |
-39.20% |
| 2019-12-31 | €4.08 Million ≈ $4.77 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Lhyfe SA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 9148800000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | €480.00K | 0.67% |
| Other Components | €163.28 Million | 227.29% |
| Total Equity | €71.84 Million | 100.00% |
Lhyfe SA Competitors by Market Cap
The table below lists competitors of Lhyfe SA ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
NuriFlex Co.Ltd
KQ:040160
|
$128.40 Million |
|
TRX Gold Corp
TO:TNX
|
$128.41 Million |
|
Ekachai Medical Care Public Company Limited
BK:EKH
|
$128.42 Million |
|
Sotkamo Silver AB
HE:SOSI1
|
$128.44 Million |
|
Verb Technology Company Inc
NASDAQ:VERB
|
$128.34 Million |
|
GRIGEO AB EO -29
F:WM8
|
$128.30 Million |
|
Greystone Housing Impact Investors LP
NYSE:GHI
|
$128.29 Million |
|
Raj Rayon Industries Limited
NSE:RAJRILTD
|
$128.27 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Lhyfe SA's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 102,487,000 to 71,838,000, a change of -30,649,000 (-29.9%).
- Net loss of 29,091,000 reduced equity.
- Share repurchases of 164,000 reduced equity.
- Other comprehensive income increased equity by 28,328,000.
- Other factors decreased equity by 29,722,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-29.09 Million | -40.5% |
| Share Repurchases | €164.00K | -0.23% |
| Other Comprehensive Income | €28.33 Million | +39.43% |
| Other Changes | €-29.72 Million | -41.37% |
| Total Change | €- | -29.91% |
Book Value vs Market Value Analysis
This analysis compares Lhyfe SA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.52x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 7.24x to 1.52x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | €0.32 | €2.29 | x |
| 2020-12-31 | €0.13 | €2.29 | x |
| 2021-12-31 | €-0.13 | €2.29 | x |
| 2022-12-31 | €2.79 | €2.29 | x |
| 2023-12-31 | €2.14 | €2.29 | x |
| 2024-12-31 | €1.51 | €2.29 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Lhyfe SA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -40.50%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -570.52%
- • Asset Turnover: 0.02x
- • Equity Multiplier: 3.10x
- Recent ROE (-40.50%) is below the historical average (-28.81%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | -15.89% | 0.00% | 0.00x | 2.04x | €-1.06 Million |
| 2020 | -64.50% | -53300.00% | 0.00x | 3.93x | €-1.85 Million |
| 2021 | 0.00% | -4428.43% | 0.00x | 0.00x | €-8.11 Million |
| 2022 | -19.32% | -4528.42% | 0.00x | 1.29x | €-39.17 Million |
| 2023 | -32.68% | -2542.75% | 0.01x | 1.96x | €-43.74 Million |
| 2024 | -40.50% | -570.52% | 0.02x | 3.10x | €-36.27 Million |
Industry Comparison
This section compares Lhyfe SA's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $774,784,325
- Average return on equity (ROE) among peers: -25.70%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Lhyfe SA (LHYFE) | €50.73 Million | -15.89% | 3.68x | $128.40 Million |
| Air Liquide SA (AI) | $5.54 Billion | 14.11% | 0.99x | $108.00 Billion |
| Arkema SA (AKE) | $1.20 Billion | 0.00% | 3.29x | $4.83 Billion |
| Afyren SAS (ALAFY) | $77.86 Million | -4.64% | 0.20x | $103.15 Million |
| Carbios (ALCRB) | $26.13 Million | -14.35% | 0.23x | $144.57 Million |
| Encres Dubuit SA (ALDUB) | $20.26 Million | -11.03% | 0.23x | $7.72 Million |
| Glob Bioenergi (ALGBE) | $6.28 Million | -217.13% | 3.05x | $335.38K |
| Vinpai SAS (ALVIN) | $2.54 Million | 0.16% | 2.31x | $15.94 Million |
| EPC Groupe (EXPL) | $101.13 Million | 5.69% | 1.75x | $526.94 Million |
| Parx Plastics NV (MLPRX) | $3.96 Million | -4.14% | 0.23x | $4.17 Million |
About Lhyfe SA
Lhyfe SA produces and supplies renewable green hydrogen for mobility and industry markets. The company designs, installs, and operates onshore, on-site, and offshore industrial green hydrogen production units that offers hydrogen through bulk deliveries, and pipelines and on-site supply. It serves chemical, metallurgy, glass, and cement industries. The company was founded in 2017 and is based in … Read more